So it seems, that OCC are about to start a follow up study, on patients who received Remplir.
While this study, is just a Observational study.
It gives the company, additional data, on the performance of Remplir, in relation to Safety and Performance.
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=386978&isReview=true
The link above, will give you more information, on the study.
IMHO.
Regards
Rossi70
- Forums
- ASX - By Stock
- OCC
- Post - Market Clinical Follow Up Study (Remplir).
OCC
orthocell limited
Add to My Watchlist
0.00%
!
$1.23

Post - Market Clinical Follow Up Study (Remplir).
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.23 |
Change
0.000(0.00%) |
Mkt cap ! $299.8M |
Open | High | Low | Value | Volume |
$1.23 | $1.23 | $1.23 | $6 | 5 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 7125 | $1.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.23 | 4095 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 7125 | 1.205 |
4 | 9594 | 1.200 |
2 | 10271 | 1.195 |
6 | 21706 | 1.190 |
2 | 1843 | 1.185 |
Price($) | Vol. | No. |
---|---|---|
1.225 | 4095 | 3 |
1.230 | 17526 | 2 |
1.235 | 30000 | 2 |
1.240 | 24202 | 3 |
1.245 | 25917 | 2 |
Last trade - 09.59am 12/08/2025 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |